medigraphic.com
ISSN 1729-519X (Print)

2017, Number 3

<< Back Next >>

Revista Habanera de Ciencias Médicas 2017; 16 (3)

Antimicrobial susceptibility in clinical samples of patients with health care associated infections

Díaz MLM, Medina GM, Duque GAC, Miguélez NR

Language: Spanish
References: 33
Page: 337-351
PDF size: 460.12 Kb.


ABSTRACT

Introduction: The health care associated infections (HCAI) are one of the major problems which affect the patients in the hospital units, both in developed countries and in countries with low resources. Objective: To identify what kind of HCAI were reported, causal microorganism and antimicrobial susceptibility in the Internal Medicine Service at the "Manuel Fajardo" clinical-surgical hospital. Material and method: Descriptive, retrospective and transversal study of 105 patients with HCAI, who were admitted in the Internal Medicine Service at the "Manuel Fajardo" clinical-surgical hospital, from January 2013 to December 2015. It was analyzed different variables. It was used descriptive statistics and it was related the national and international information with the obtained results. Results: It were predominated the patients with age over 60 years. The more common diagnosis was broncho-pneumonia in 58 patients (55.2%). The principal causal microorganism for broncho-pneumonia, the tracheo-bronchitis and the pressure ulcers was Pseudomona spp.; while for urinary tract infection and flebitis-cellulitis and abscess were E. coli and S. aureus respectively. Pseudomona spp. and E. coli showed high resistance to cephalosporins of the first, second and third generation tested and other kinds of antibiotics; however, for the amynoglucosides and for Cefepime the sensibility was favourable. The susceptibility of S. aureus showed very adverse results, because only for Amikacin and Vancomicin had acceptable sensibility. Conclusions: The HCAI predominated in an aged population and were caused by a diversity of microorganisms, principally Pseudomona spp., E. coli and S. aureus, which showed high antimicrobial resistance.


REFERENCES

  1. Miloševi I, Kora M, Stevanovi G. Nosocomial infections in the Intesive Care Unit, Univerisity Hospital for Infectious and Tropical Diseases, Belgrade, Serbia. Vojnosanit Pregl. 2014; 71(2):131-6.

  2. 2.Zhou Y, Zhang D, Chen Y, Zhou S, Pan S, Huang Y, et al. Healthcare-Associated Infections and Shanghai Clinicians: A Multicenter Cross-Sectional Study. Plos One. [Internet]. Aug 2014 Consultado: 2016 Sep 12]; 9(8).Disponible en: http://journals.plos.org/plosone/article/asset?id=10.1371/journal.pone.0105838.pdf

  3. European Centerfor Disease Prevention and Control. Annual epidemiological report on communicable diseases in Europe 2008 European Center for Disease Prevention and Control. [Internet]. Consultado: 2016 Oct 20] Disponible en: http://www.ecdc.europa.eu/en/publications/Publications/0812_SUR_Annual_Epi-demiological_Report_2008.pdf

  4. Douglas Scott II R. The direct medical costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention. Centers for Disease Control and Prevention. [Internet]. 2009 Mar. Consultado: 2016 Oct 20. Disponible en: http://www.cdc.gov/HAI/pdfs/hai/Scott_CostPaper.pdf

  5. 5.Center for disease control and prevention; Healthcare-associated Infections; HAI Data and Statistics. [Internet]. 2016. Mar Consultado: 2016 Sep 1] Disponible en: http://www.cdc.gov/hai/surveillance/index.html

  6. Bernal M, Guzmán M. El antibiograma de discos. Normalización de la técnica de Kirby-Bauer. Biomédica. 1984; 4(3-4): 112-21.

  7. 7.Arias Gallardo AI, Moré Hernández N, Alfonso Alfonso IF. Envejecimiento poblacional: nuevo reto para el plan de estudio de la carrera de Medicina. Edu Me Centro [Internet]. 2015 Consultado: 2016 Sep 1. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2077-28742015000300016&nrm=iso

  8. 8.Baster Moro JC. Adultos mayores en funciones de cuidadores de ancianos. Rev Cubana Salud Pública [Internet]. 2012 Consultado: 2016 Sep 1]; 38(1):[aprox. 5 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662012000100016&lng=es&nrm=iso&tlng=es

  9. Struelens MJ, Baudouin B. Hospital infection control. En: Cohen J, Powderly WG. Infectious diseases, 2nd ed. Edinburgh: Mosby; 2004. p. 927-45.

  10. Rosenthal VD, Maki DG, Jamulitrat S, Medeiros EA, Kumar-Todi S, Yepes-Gómez D, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June. 2009. Am J Infect Control. 2010; 38(2):95-106. e2

  11. Gardam M, Reason P, Gitterman L. Healthcare-associated infections: New initiatives and continuing challenges. Health Q. 2012. 15 (special issue):36-41. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/22874445

  12. Wenzel RP: Health care-associated infections: major issues in the early years of the 21st century. Clin Infect Dis. 2007, 45(Suppl 1):S85-S88.

  13. Drozdov D, Schwarz S, Kutz A, Grolimund E, Rast AC, Steiner D, et al. Procalcitonin and pyuria-based algorithm reduces antibiotic use in urinary tract infections: a randomized controlled trial. BMC Medicine [Internet].2015 Consultado: 2016 Sep 1; 13:104: Disponible en: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-015-0347-y

  14. Villalobos AP, Barrero LI, Rivera SM, Ovalle MV, Valera D. Vigilancia de infecciones asociadas a la atención en salud, resistencia bacteriana y consumo de antibióticos en hospitales de alta complejidad, Colombia, 2011. Biomédica. 2014; 34(Supl.1):67-80.

  15. Zúñiga A, Mañalich J, Cortés R. ¿Estetoscopio o estafiloscopio? Potencial vector en las infecciones asociadas a la atención de la salud. Rev Chilena Infectol. 2016; 33(1):19-25.

  16. Salazar-Holguín HD, Cisneros-Robledo ME. Resistencia a los antimicrobianos de agentes causales de las principales infecciones nosocomiales. Rev Med Inst Mex Seguro Soc. 2016; 54(4):462-71.

  17. Rajabi M, Abdar ME, Rafiei H, Aflatoonia MR, Abdar ZE. Nosocomial infections and epidemiology of antibiotic resistance in teaching hospitals in south east of Iran. Global J Health Sci. 2016; 8(2):190-97.

  18. Matzumura Kasano J, Apolaya Segura M, Gutiérrez Crespo H, Kiyamu Tang S, Sotomayor Salas J. Perfil epidemiológico de las infecciones intrahospitalarias en la Clínica Centenario Peruano Japonesa durante 2011. Rev Horiz Med. 2012; 12(4):17-22.

  19. Rincón-León HA, Navarro-Fuentes KR. Tendencias de resistencia antimicrobiana en patógenos aislados de infecciones nosocomiales. Rev Med Inst Mex Seguro Soc. 2016; 54(1):32-41.

  20. Bergogne-Bérézin E. Current guidelines for the treatment and prevention of nosocomial infections. Drugs. 1999; 58(1):51-67.

  21. Alí Munive A, Ortiz Ruiz G, Dueñas Castell C. Consenso colombiano de neumonía nosocomial 2013. Infectio. [Internet] 2013 Jan-Mar Consultado: 2016 Sep 12]; 17(1):6-18. Disponible en: http://ac.els-cdn.com/S0123939213700432/1-s2.0-S0123939213700432-main.pdf?_tid=6c4f2cda-92f9-11e6-ad91-00000aab0f27&acdnat=1476551244_ce8f0dffe58ba020bf98f5ce9862074

  22. González Alemán M. Resistencia antimicrobiana, una amenaza mundial (Editorial). Rev Cubana Pediat [Internet]. 2013 Consultado: 2016 Sep 2]; 85(4):414-7. Disponible en: http://scielo.sld.cu/pdf/ped/v85n4/ped01413.pdf

  23. Pardo Serrano FJ, Tirado Balaguer MD, García Zúñiga ED, Granados Ortega J, Campos Aznar A, Moreno Muñoz R. Pseudomonas aeruginosa: resistencia antimicrobiana en aislados clínicos. Castellón 2004-2008. Rev Esp Quimioter. 2010; 23(1):20-6.

  24. Suárez Trueba B, Milián Samper Y, Espinosa Rivera F, Hart Cáceres M, Llanes Rodríguez N, Martínez Batista ML. Susceptibilidad antimicrobiana y mecanismos de resistencia de Escherichia coli aisladas a partir de urocultivos en un hospital de tercer nivel. Rev Cub Med. [Internet] 2014 Consultado: 2 Sep 2016]; 53(1):3-13Disponible en: http://scielo.sld.cu/pdf/med/v53n1/med02114.pdf

  25. Saonuam P, Hiransuthikul N, Suankratay C, Malathum K, Danchaivijitr S. Risk factors for nosocomial infections caused by extended-spectrum β-lactamase producing Escherichia coli or Klebsiella pneumoniae in Thailand. Asian Biomedicine. 2008; 2(6):485-91.

  26. De Angelis G, Restuccia G, Silia Venturiello S, Cauda R, Malhotra-Kumar S, Goossens H, et al. Nosocomial acquisition of methicillin-resistant Staphyloccocus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) Enterobacteriaceae in hospitalised patients: a prospective multicenter study. BMC Infectious Diseases [Internet] 2012 Consultado: 2016 Sep 2]; 12-74. Disponible en: http://www.biomedcentral.com/1471-2334/12/74

  27. Mataseje LF, Bryce E, Roscoe D, Boyd DA, Embree J, Gravel D, et al. Carbapenem-resistant Gram-negative bacilli in Canada 2009–10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP). J Antimicrob Chemother [Internet]. 2012 Mar Consultado: 2016 Sep 12]; 67(6):1359-1367.Disponible en: http://jac.oxfordjournals.org/content/67/6/1359.full

  28. Scherbaum M, Kösters K, Mürbeth RE, Ngoa UA, Kremsner PG, Lell B, et al. Incidence, pathogens and resistance patterns of nosocomial infections at a rural hospital in Gabon. [Internet] BMC Infectious Diseases [Internet]. 2014 Consultado: 2016 Sep 21]; 14:124. Disponible en: http://www.biomedcentral.com/1471-2334/14/124

  29. Leblebicioglu H, Erben N, Rosenthal VD, Atasay B, Erbay A, Unal S, et al. International nosocomial infection control consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003-2012. Ann Clin Microb Antimicrob [Internet] 2014 Nov Consultado: 21 Septiembre 2016]; 13:51. Disponible en: http://www.ann-clinmicrobiol.com/content/13/1/51

  30. Al-Talib HI, Yean CY, Al-Jashamya K, Hasan H. Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002-2007. Ann Saudi Med. [Internet]. 2010 Sep-Oct Consultado: 2016 sep 1. 30(5):358-63. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941247/

  31. Armas Fernández A, Suárez Trueba B, Crespo Toledo N, Suárez Casal A. Resistencia de Staphylococcus aureus a la meticilina en aislamientos nosocomiales en un hospital provincial. Gaceta Médica Espirituana [Internet] 2014 Consultado: 2016 Sep 2]; 17(3):[11 p.]. Disponible en: http://scieloprueba.sld.cu/pdf/gme/v17n3/GME11315.pdf

  32. Espadinha D, Faria NA, Miragaia M, Lito LM, Melo-Cristino J, et al. (2013) Extensive Dissemination of Methicillin-Resistant Staphylococcus aureus (MRSA) between the Hospital and the Community in a Country with a High Prevalence of Nosocomial MRSA. PLoS ONE [Internet] 2013 Apr Consultado: 2016 Sep 2; 8(4). Disponible en: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0059960

  33. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Guideline for isolation precautions: Preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007 Dic; Consultado: 2016 Sep 1; 35(10 suppl 2): S65-164. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/18068815




2020     |     www.medigraphic.com